## Analysis of Diabetes Epidemiology in India ### Correct Statements (Options 0, 1, 2) **Key Point:** India is the "diabetes capital of the world" with the second-highest absolute burden after China, driven by rapid urbanization, lifestyle changes, and genetic predisposition. | Feature | Finding | |---------|----------| | Global rank | 2nd (after China) | | Estimated cases | >77 million adults | | Urban vs rural prevalence | 2–3× higher in urban areas | | Age of onset vs Caucasians | 10–15 years earlier in Indians | | Phenotype | Lean/normal BMI diabetes common | **High-Yield:** The earlier age of onset in Indians (often 35–45 years vs 55–65 years in Caucasians) reflects both genetic susceptibility and rapid lifestyle transition. This is termed the "Asian Indian Phenotype" — characterized by central obesity, insulin resistance, and dyslipidemia even at lower BMI thresholds. ### The Incorrect Statement (Option 3) **Warning:** Gestational diabetes mellitus (GDM) carries a **much higher** recurrence risk in Indian women. **Clinical Pearl:** Women with prior GDM have a 30–50% risk of recurrence in subsequent pregnancies, and a 50–80% lifetime risk of developing Type 2 DM within 10–15 years. This makes GDM a critical screening and intervention opportunity in India's diabetes prevention strategy. **Mnemonic:** GDM Risk Trajectory — **RECUR** - **R**ecurrence in next pregnancy: 30–50% - **E**arly Type 2 DM: 50–80% lifetime - **C**ardiovascular risk: elevated - **U**nderdiagnosis: common in India - **R**equires lifestyle + metformin intervention ### Why This Matters The statement claiming <5% recurrence is a **trap answer** that underestimates the true epidemiological burden and clinical significance of GDM as a gateway to Type 2 DM in Indian women.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.